4.6 Article

Exploring Effects of Chitosan Oligosaccharides on the DSS-Induced Intestinal Barrier Impairment In Vitro and In Vivo

期刊

MOLECULES
卷 26, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/molecules26082199

关键词

chitosan oligosaccharide; intestinal barrier; mucus; intestinal tight junction; inflammatory bowel disease

资金

  1. National Key Research and Development Program of China [2019YFD0902000]
  2. National Natural Science Foundation of China [31870802]

向作者/读者索取更多资源

Chitosan oligosaccharide has been shown to have a protective effect on intestinal mucus in inflammatory bowel disease, improving DSS-induced mucus defects, with its structural characteristics playing a key role in this activity.
Intestinal barrier dysfunction is an essential pathological change in inflammatory bowel disease (IBD). The mucus layer and the intestinal epithelial tight junction act together to maintain barrier integrity. Studies showed that chitosan oligosaccharide (COS) had a positive effect on gut health, effectively protecting the intestinal barrier in IBD. However, these studies usually focused on its impact on the intestinal epithelial tight junction. The influence of COS on the intestinal mucus layer is still poorly understood. In this study, we explored the effect of COS on intestinal mucus in vitro using human colonic mucus-secreted HT-29 cells. COS relieved DSS (dextran sulfate sodium)-induced mucus defects. Additionally, the structural characteristics of COS greatly influenced this activity. Finally, we evaluated the protective effect of COS on intestinal barrier function in mice with DSS-induced colitis. The results indicated that COS could manipulate intestinal mucus production, which likely contributed to its intestinal protective effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据